Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty

Not Applicable

Recruiting

• Conditions: Analgesia; Hip Arthropathy; Post Operative Pain

• Registration Number: NCT06317870
• Lead Sponsor: Centre Hospitalier Universitaire Vaudois

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-3-4
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Inclusion Criteria:<br><br> - Male and female patients<br><br> - ASA (American Society of Anaesthesiologists) I-III<br><br> - 18 years of age or older<br><br> - Patients scheduled for elective primary hip arthroplasty<br><br> - Able to give written conformed consent autonomously<br><br>Exclusion Criteria:<br><br> - Refusal or inability to give consent<br><br> - Allergy to any of: ropivacaine, paracetamol, ibuprofen, ketorolac, morphine,<br> ondansetron or dexamethasone<br><br> - Bleeding diathesis<br><br> - Neurological deficit of the operative side<br><br> - Existing preoperative opioid use<br><br> - Renal insufficiency (GFR<30ml/min according to the Cockroft-Gault formula)<br><br> - Hepatic insufficiency<br><br> - Pregnant or lactating women

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cumulative postoperative morphine consumption at day 1

Secondary Outcome Measures

Name	Time	Method
Morphine consumption in the recovery room;PCA administered morphine consumption at day 2;rest and dynamic pain scores;Incidence of postoperative nausea and vomiting;Incidence of pruritus;Incidence of urinary retention requiring bladder catheterisation;Duration of analgesia;operated limb quadriceps strength;Walking test